Recist vs iRecist: Clinically Significant?

Raquel Perez-Lopez Vall dHebron Institute of Oncology (VHIO)Principal Investigator-Radiomics Group discusses Recist vs iRecist: Clinically Significant? at the Kidney Cancer Association International Symposium 2019 at Dubrovnik, Croatia

 

 

 

 

recist vs irecist, kidney cancer association international symposium 2019, clinically significant